
Forest helps Microbia develop, sell linaclotide in the US
Executive Summary
Microbia (focused on gastrointestinal and cardiovascular therapeutics) and specialty pharma Forest Laboratories will co-develop and co-promote Microbia's linaclotide in the US.
Deal Industry
- Biotechnology
- Pharmaceuticals
-
Pharmaceuticals
- Specialty Pharmaceuticals
Deal Status
- Final
Deal Type
-
Alliance
- Co-Promotion
- Includes Royalty or Profit Split Information
- R&D and Marketing (Licensing)
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com